These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16619056)

  • 1. Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial.
    Wynne K; Park AJ; Small CJ; Meeran K; Ghatei MA; Frost GS; Bloom SR
    Int J Obes (Lond); 2006 Dec; 30(12):1729-36. PubMed ID: 16619056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.
    Wynne K; Park AJ; Small CJ; Patterson M; Ellis SM; Murphy KG; Wren AM; Frost GS; Meeran K; Ghatei MA; Bloom SR
    Diabetes; 2005 Aug; 54(8):2390-5. PubMed ID: 16046306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.
    Basolo A; Burkholder J; Osgood K; Graham A; Bundrick S; Frankl J; Piaggi P; Thearle MS; Krakoff J
    Metabolism; 2018 Aug; 85():116-125. PubMed ID: 29596853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
    Tremblay A; Chaput JP; Bérubé-Parent S; Prud'homme D; Leblanc C; Alméras N; Després JP
    Eur J Clin Pharmacol; 2007 Feb; 63(2):123-34. PubMed ID: 17200837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.
    Shankar SS; Shankar RR; Mixson LA; Miller DL; Pramanik B; O'Dowd AK; Williams DM; Frederick CB; Beals CR; Stoch SA; Steinberg HO; Kelley DE
    Diabetes; 2018 Jun; 67(6):1105-1112. PubMed ID: 29545266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure.
    Martin CK; Redman LM; Zhang J; Sanchez M; Anderson CM; Smith SR; Ravussin E
    J Clin Endocrinol Metab; 2011 Mar; 96(3):837-45. PubMed ID: 21190985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
    Bergmann NC; Lund A; Gasbjerg LS; Meessen ECE; Andersen MM; Bergmann S; Hartmann B; Holst JJ; Jessen L; Christensen MB; Vilsbøll T; Knop FK
    Diabetologia; 2019 Apr; 62(4):665-675. PubMed ID: 30683945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides.
    Rigamonti AE; Casnici C; Marelli O; De Col A; Tamini S; Lucchetti E; Tringali G; De Micheli R; Abbruzzese L; Bortolotti M; Cella SG; Sartorio A
    Nutr Res; 2018 Apr; 52():71-79. PubMed ID: 29530622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in energy balance following exenatide administration.
    Bradley DP; Kulstad R; Racine N; Shenker Y; Meredith M; Schoeller DA
    Appl Physiol Nutr Metab; 2012 Oct; 37(5):893-9. PubMed ID: 22735035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.
    Field BC; Wren AM; Peters V; Baynes KC; Martin NM; Patterson M; Alsaraf S; Amber V; Wynne K; Ghatei MA; Bloom SR
    Diabetes; 2010 Jul; 59(7):1635-9. PubMed ID: 20357366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
    Fogteloo AJ; Pijl H; Frölich M; McCamish M; Meinders AE
    Diabetes Nutr Metab; 2003 Apr; 16(2):109-14. PubMed ID: 12846450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
    Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
    Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
    Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects.
    Chevassus H; Gaillard JB; Farret A; Costa F; Gabillaud I; Mas E; Dupuy AM; Michel F; Cantié C; Renard E; Galtier F; Petit P
    Eur J Clin Pharmacol; 2010 May; 66(5):449-55. PubMed ID: 20020282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ascorbic acid on the thermic effect of feeding in overweight and obese adult humans.
    Newsom SA; Paxton RJ; Rynn GM; Bell C
    Obesity (Silver Spring); 2008 Aug; 16(8):1749-54. PubMed ID: 18551121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.
    Bottin JH; Swann JR; Cropp E; Chambers ES; Ford HE; Ghatei MA; Frost GS
    Br J Nutr; 2016 Jul; 116(2):360-74. PubMed ID: 27198187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Inulin Propionate Ester Incorporated into Palatable Food Products on Appetite and Resting Energy Expenditure: A Randomised Crossover Study.
    Byrne CS; Chambers ES; Preston T; Tedford C; Brignardello J; Garcia-Perez I; Holmes E; Wallis GA; Morrison DJ; Frost GS
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30995824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sibutramine intake on resting and exercise physiological responses.
    Rotstein A; Inbar O; Vaisman N
    Ann Nutr Metab; 2008; 52(1):17-23. PubMed ID: 18230966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycium barbarum increases caloric expenditure and decreases waist circumference in healthy overweight men and women: pilot study.
    Amagase H; Nance DM
    J Am Coll Nutr; 2011 Oct; 30(5):304-9. PubMed ID: 22081616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.